Gibbs Andrew 4
4 · Myriad Pharmaceuticals, Inc. · Filed Jun 18, 2010
Insider Transaction Report
Form 4
Gibbs Andrew
Vice President, Legal
Transactions
- Sale
Common Stock
2010-06-16$3.78/sh−1,153$4,359→ 7,847 total
Footnotes (1)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 31, 2010, and was made to fund certain out-of-pocket tax withholding liabilities associated with the vesting of restricted stock units granted on July 1, 2009.